LivaNova PLC - Ordinary Shares (LIVN) analyst actions
Rating and price-target actions on LIVN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LIVN overview →
1 measured LIVN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression | Press release | +0.27% | +0.61% |
Keep exploring
More LIVN: earnings → · SEC filings → · LIVN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | 275 | -0.27% | 42% |
| Evolus, Inc. (EOLS) | 275 | +0.08% | 51% |
| Puma Biotechnology Inc (PBYI) | 274 | +0.44% | 55% |
| PRANA BIOTECH (PRAN) | 274 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.